Frederick G. Vogt
General Counsel, Iovance Biotherapeutics.
Companies
- Iovance BiotherapeuticsBoard member Sep 5, 2024 to now1
- Iovance BiotherapeuticsChief executive officer Jun 16, 2021 to now2
- Iovance BiotherapeuticsGeneral counsel Oct 20, 2017 to now3
- Iovance BiotherapeuticsOfficer Mar 6, 2023 to Mar 6, 20234
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Iovance Biotherapeutics IOVA595,447 shares5$8.8M at $14.72Sep 8, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 8, 2026Shares withheld for tax 6,638 shares at $8.70 of Iovance Biotherapeutics5
- Sep 8, 2026Exercised options 15,626 shares of Iovance Biotherapeutics5
- Sep 1, 2026Shares withheld for tax 17,702 shares at $8.28 of Iovance Biotherapeutics6
- Sep 1, 2026Exercised options 41,669 shares of Iovance Biotherapeutics6
- Jun 5, 2026Shares withheld for tax 6,638 shares at $4.23 of Iovance Biotherapeutics7
- Jun 5, 2026Exercised options 15,625 shares of Iovance Biotherapeutics7
- Jun 1, 2026Shares withheld for tax 17,701 shares at $3.96 of Iovance Biotherapeutics8
- Jun 1, 2026Exercised options 41,668 shares of Iovance Biotherapeutics8
- Mar 5, 2026Shares withheld for tax 26,755 shares at $4.58 of Iovance Biotherapeutics9
- Mar 5, 2026Exercised options 62,493 shares of Iovance Biotherapeutics9
- Mar 2, 2026Shares withheld for tax 22,809 shares at $3.79 of Iovance Biotherapeutics10
- Mar 2, 2026Exercised options 52,087 shares of Iovance Biotherapeutics10
- Dec 2, 2025Shares withheld for tax 4,426 shares at $2.14 of Iovance Biotherapeutics11
- Dec 2, 2025Exercised options 10,417 shares of Iovance Biotherapeutics11
- Dec 1, 2025Shares withheld for tax 17,701 shares at $2.23 of Iovance Biotherapeutics11
- Dec 1, 2025Exercised options 41,669 shares of Iovance Biotherapeutics11
- Sep 2, 2025Shares withheld for tax 22,127 shares at $2.19 of Iovance Biotherapeutics12
- Sep 2, 2025Exercised options 52,086 shares of Iovance Biotherapeutics12
- Jun 2, 2025Shares withheld for tax 22,127 shares at $1.76 of Iovance Biotherapeutics13
- Jun 2, 2025Exercised options 52,085 shares of Iovance Biotherapeutics13
- May 14, 2025Bought 25,000 shares at $1.69 of Iovance Biotherapeutics14
- Mar 3, 2025Shares withheld for tax 95,413 shares at $4.04 of Iovance Biotherapeutics15
- Mar 3, 2025Exercised options 223,943 shares of Iovance Biotherapeutics15
- Jan 14, 2025Shares withheld for tax 9,955 shares at $5.89 of Iovance Biotherapeutics16
- Jan 14, 2025Exercised options 20,835 shares of Iovance Biotherapeutics16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARIovance Biotherapeutics, Officer
- 5
- 6SEC EDGARForm 4 filed Sep 3, 2026
- 7SEC EDGARForm 4 filed Jun 9, 2026
- 8SEC EDGARForm 4 filed Jun 3, 2026
- 9SEC EDGARForm 4 filed Mar 6, 2026
- 10SEC EDGARForm 4 filed Mar 4, 2026
- 11SEC EDGARForm 4 filed Dec 3, 2025
- 12SEC EDGARForm 4 filed Sep 4, 2025
- 13SEC EDGARForm 4 filed Jun 4, 2025
- 14SEC EDGARForm 4 filed May 16, 2025
- 15SEC EDGARForm 4 filed Mar 5, 2025
- 16SEC EDGARForm 4 filed Jan 16, 2025